Presidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) April 22, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by financialcontent. Read more Source: https://www.financialcontent.com/article/getnews-2026-4-21-presidential-executive-order-to-accelerate-approval-of-psychedelic-medications-those-being-developed-by-nrx-pharmaceuticals-inc-nasdaq-nrxp